Recent News

• 02.09.2026 - Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
• 01.02.2026 - Nutriband CEO Publishes Letter to Shareholders
• 12.29.2025 - Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio
• 12.25.2025 - Nutriband Inc. Shares Interview with Chairman Serguei Melnik from NobleCon21
• 12.24.2025 - Nutriband Inc. Announces 2026 Annual Shareholders Meeting
• 12.22.2025 - Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
• 12.22.2025 - Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
• 12.08.2025 - The Power of the Patch: Serguei Melnik Shares How Nutriband Is Disrupting The Drug Delivery Business $NTRB
• 12.06.2025 - Marquis Who's Who Honors Serguei V. Melnik for Success in Business
• 12.05.2025 - Nutriband Inc. Releases Full Presentation from Noble Capital Markets Emerging Growth Conference 2025

Recent Filings

• 02.03.2026 - 8-K Current report
• 12.30.2025 - EX-99.1 EX-99.1
• 12.30.2025 - 8-K Current report
• 12.19.2025 - DEF 14A Other definitive proxy statements
• 12.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.25.2025 - 5 Annual statement of changes in beneficial ownership of securities
• 10.28.2025 - 8-K Current report
• 10.28.2025 - EX-99.1 EX-99.1